Do you want to read an article? Please log in or register.
<i>Acanthamoeba</i> keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases
Further Publications
Related content
Macular Diseases
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes
Ophthalmol Retina.
Ciulla TA, Hussain RM, Pollack JS, Williams DF
doi: 10.1016/j.oret.2019.05.017.
RECOMMENDED
Ocular Oncology
Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture
★ 2
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
Ophthalmol Retina.
Shields CL, Khoo CTL, Mazloumi M, Mashayekhi A, Shields JA
doi: 10.1016/j.oret.2019.10.009.
Cornea and Corneal Diseases
Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes
Am J Ophthalmol.
Durrani AF, Faith SC, Kowalski RP, Yu M, Romanowski E, Shanks R, Dhaliwal D1, Jhanji V
doi: 10.1016/j.ajo.2018.
COMMENTED
Ocular Oncology
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2019.5132.
RECOMMENDED
Surgery and Intervention
Iris hooks versus a pupil expansion ring: Operating times, complications, and visual acuity outcomes in small pupil cases
J Cataract Refract Surg.
Nderitu P, Ursell P
doi: 10.1016/j.jcrs.2018.08.038.
Blindness and Vision ImpairmentSurgery and Intervention
Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis
Sci Rep
Ting DSJ, Henein C, Said DG, Dua HS
doi: 10.1038/s41598-021-92366-x
Macular Diseases
Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)
Acta Ophthalmol.
Schroeder M, Westborg I, Lövestam Adrian M
doi: 10.1111/aos.14239.
Retinal DiseasesSurgery and Intervention
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol
Glassman AR, Beaulieu WT, Maguire MG, Antoszyk AN, Chow CC, Elman MJ, Jampol LM, Salehi-Had H, Sun JK, DRCR Retina Network.
doi: 10.1001/jamaophthalmol.2021.1110
Macular Diseases
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial
JAMA Ophthalmol.
Bressler SB, Odia I, Maguire MG, Dhoot DS, Glassman AR, Jampol LM, Marcus DM, Solomon SD, Sun JK; Diabetic Retinopathy Clinical Research Network
doi: 10.1001/jamaophthalmol.